Adams : 25-04-2019Result of Meeting

RNS Number : 1085X

Concepta PLC

25 April 2019

25 April 2019

Concepta plc

Result of Meeting

At the general mee ng of the Company held earlier today, all the resolu ons were passed by shareholders. The 76,750,000 new ordinary shares of 2.5 pence per share ("Ordinary Shares") issued in the placing at 3 pence per share, as announced on 8 April 2019, are expected to be admitted to trading at 8.00 a.m. on 26 April 2019.

The Group will issue its 2018 Financial Year preliminary results announcement on 14th May 2019.

Enquiries

Company:www.conceptaplc.com, Product:www.mylotus.com

Matthew Walls, Chairman

Tel: [phone]

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin

Tel: [phone]

Novum Securities

Colin Rowbury

[phone]

About Concepta Plc:

Concepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalised mobile health market with a primary focus on hormone tes ng and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.

myLotus® is currently the only consumer product which allows both quan ta ve and qualita ve home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovula on and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception

rates and early diagnosis of fer lity issues. The proposi on of myLotus® is to empower women to be er understand their hormone levels and menstrual cycle and help women conceive naturally by iden fying their window of fer lity and optimal time for conception.

The Company has received CE-mark cer fica on for myLotus® and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2019.

myLotus® is expected to be beneficial to users who have been unable to conceive a er 6 months of trying. This highly mo vated target group of women won't typically be offered medical interven on un l a er 12 months of unsuccessfully trying to conceive, with IVF not usually offered un l a er two years of trying to conceive. Research indicates couples start to take posi ve ac on ahead of this me typically with li le medical support to help them do so.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] visit www.rns.com.

END

ROMIAMMTMBMTBAL